23 results
8-K
EX-99.1
MLYS
Mineralys Therapeutics, Inc.
13 Aug 24
Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
4:07pm
and studies of lorundrostat are not necessarily predictive of future results; our ability to maintain undisrupted business operations due to any pandemic
8-K
MLYS
Mineralys Therapeutics, Inc.
10 Jun 24
Other Events
4:02pm
of future results; the Company’s ability to maintain undisrupted business operations due to any pandemic or future public health concerns; regulatory
8-K
EX-99.1
MLYS
Mineralys Therapeutics, Inc.
9 May 24
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:07am
of future results; our ability to maintain undisrupted business operations due to any pandemic or future public health concerns; regulatory
8-K
EX-99.1
oj61qoy
21 Mar 24
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:43am
8-K
EX-99
q0vpsgoojrf3n bedvsv
4 Jan 24
Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer
4:10pm
8-K
EX-99.1
37rl34cv7ra5tqrvt7te
22 Dec 23
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
9:04am
8-K
r533x wk09u
13 Nov 23
Regulation FD Disclosure
8:20am
8-K
EX-99.1
ytcktbmv76
13 Nov 23
Regulation FD Disclosure
8:20am
8-K
EX-99.1
7fzhsj pg07
7 Nov 23
Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
rvj18 ocnpapck
2 Nov 23
Regulation FD Disclosure
10:06am
8-K
EX-99.1
7tvu7f8 n9
7 Aug 23
Mineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
EX-99.1
wg840b1uuqi9h2b50r
17 Jul 23
Regulation FD Disclosure
4:03pm
10-Q
0nkrmh
15 May 23
Quarterly report
5:25pm
8-K
EX-99.1
6xt33hh0icx2 c4vy8
15 May 23
Mineralys Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:04pm
DRS/A
b6xzg 43jwmbg
29 Dec 22
Draft registration statement (amended)
12:00am